1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Christopher Patrick Smith: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER onaBoNT-A, Oxybutynin ER - Overactive Bladder | Phase 3 | Unknown | Christopher Patrick Smith | 36 | 2013-08-01 | 2016-08-30 |
Hereditary Sensory and Autonomic Neuropathies (1) · Spinal Cord Injuries (1) · Urinary Bladder, Overactive (1) · Urinary Incontinence (1)
Botulinum Toxins, Type A (1) · Tolterodine Tartrate (1) · onabotulinum toxin A (1) · oxybutynin (1)
United States (1)